Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
暂无分享,去创建一个
Marc A Pfeffer | M. Pfeffer | M. Sabatine | E. Braunwald | F. Sacks | T. White | C. Packard | C. Rowland | T. Kirchgessner | D. Shiffman | J. Shepherd | H. Campos | J. Devlin | O. Iakoubova | Marc S Sabatine | Eugene Braunwald | James Shepherd | Dov Shiffman | Charles M Rowland | Andre R Arellano | Bradford A Young | James J Devlin | Hannia Campos | Frank M Sacks | Todd G Kirchgessner | A. Arellano | Olga A Iakoubova | Carmen H Tong | Christopher J Packard | Thomas J White | B. Young | C. Tong | Bradford A. Young
[1] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[2] E. Hawe,et al. Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension , 2003, Hypertension.
[3] M. Sabatine,et al. Asp92Asn Polymorphism in the Myeloid IgA Fc Receptor Is Associated With Myocardial Infarction in Two Disparate Populations: CARE and WOSCOPS , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[4] Jonathan C. Cohen. Genetic Approaches to Coronary Heart Disease , 2006 .
[5] A. Lupas,et al. Predicting coiled coils from protein sequences , 1991, Science.
[6] M. Weiner,et al. Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. , 2000, Cytometry.
[7] A. Henney,et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. , 1994, British heart journal.
[8] Localization of a small genomic region associated with elevated ACE. , 2000, American journal of human genetics.
[9] N. Hirokawa,et al. All kinesin superfamily protein, KIF, genes in mouse and human , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[11] S. Grundy,et al. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.
[12] E. Topol,et al. Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. , 2004, American heart journal.
[13] Bruce S. Weir,et al. Genetic Data Analysis: Methods for Discrete Population Genetic Data. , 1991 .
[14] G. Lowe,et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.
[15] F R Rosendaal,et al. Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased , 1998 .
[16] M. H.,et al. LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 AS AN INDEPENDENT PREDICTOR OF CORONARY HEART DISEASE , 2000 .
[17] Ames,et al. PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .
[18] N. Samani,et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. , 1996, Circulation.
[19] A. Gardemann,et al. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. , 1999, Blood.
[20] S. Seiler,et al. Cargo binding and regulatory sites in the tail of fungal conventional kinesin , 2000, Nature Cell Biology.
[21] Thomas A Trikalinos,et al. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. , 2006, American journal of epidemiology.
[22] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[23] T. Murohara,et al. Preventive cardiology: abstractAssociation of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors , 2004 .
[24] A. Hamsten,et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] E. Hawe,et al. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study , 2001, The Lancet.
[26] M Freedman,et al. Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction , 2001, Circulation.
[27] D. Arveiler,et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. , 2000, Human molecular genetics.
[28] E. Topol,et al. Identification of four gene variants associated with myocardial infarction. , 2005, American journal of human genetics.
[29] I. Simpson,et al. Independent effects of the −219 G>T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study , 2003, European Journal of Human Genetics.
[30] I. Simpson,et al. Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. , 2003, European journal of human genetics : EJHG.
[31] L. Tiret,et al. Genetic Polymorphisms and Coronary Artery Disease in the South of France , 2000, Thrombosis and Haemostasis.
[32] D. Seog,et al. Molecular Motor Proteins of the Kinesin Superfamily Proteins (KIFs): Structure, Cargo and Disease , 2004, Journal of Korean medical science.
[33] M. Margaglione,et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[34] S. Ye,et al. Association of the lymphotoxin-α gene Thr26Asn polymorphism with severity of coronary atherosclerosis , 2005, Genes and Immunity.
[35] Y. Ohnishi,et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.
[36] G. Fonarow,et al. Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways , 2004, Circulation.
[37] J. Rotter,et al. Genetic markers: progress and potential for cardiovascular disease. , 2004, Circulation.
[38] Robert C. Elston,et al. On Fisher's Method of Combining p-Values , 1991 .
[39] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[40] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[41] G. Fonarow,et al. Genetic Basis of Atherosclerosis: Part II: Clinical Implications , 2004, Circulation.
[42] J. Pankow,et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. , 2007, American journal of epidemiology.
[43] F R Rosendaal,et al. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. , 1997, Blood.
[44] C. Stefanadis,et al. Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction. , 2006, Journal of the American College of Cardiology.